Enroflak®5%

Enroflak®5%

Sterile Injectable Solution

Therapeutically classification: Antibiotic

Composition: Each ml Contains:

Enrofloxacin 50 mg

Target species: Cattle, Sheep, Goats, Dogs and Cats

Enroflak®5%

Sterile Injectable Solution

Therapeutically classification: Antibiotic

Composition: Each ml Contains:

Enrofloxacin 50 mg

Target species: Cattle, Sheep, Goats, Dogs and Cats

Indications:

Enroflak® 5% is used for treatment of diseases associated with enrofloxacin-sensitive gram-negative and gram-positive bacteria as E. coli, Salmonella spp., Pasteurella spp., Bordetella spp., Haemophilus spp. Staphylococcus spp. and also Mycoplasma. Due to its broad spectrum of activity, it can be used in single or mixed bacterial infections of respiratory, digestive and urinary systems, the skin and wounds.

Mechanism of action:

Enrofloxacin is a synthetic chemotherapeutic antibiotic from the class of fluoroquinolones. It has bactericidal activity against a broad spectrum of gram negative and gram positive bacteria. Fluoroquinolones interfere with bacterial DNA metabolism by the inhibition of two enzymes, topoisomerase II (DNA gyrase) and topoisomerase IV. It is a bactericidal agent.

Dosage & Administration:

Cattle, Sheep, Goats:

2.5-5 mg/kg B.W. (0.5-1 ml per 10 kg B.W.), by IM or SC injection, daily for 3-5 days.

In case of mastitis caused by E.coli, 5 mg/kg B.W., for slow IV administration, for 2 days

Dogs and cats:

2/5-5 mg/kg B.W. (0.5-1 ml per 10 kg B.W.), by SC injection, daily.

Withdrawal time:

IM-SC administration: 

Meat: 13 days after the last treatment

 IV administration:

Meat: 4 days after the last treatment

Contra-indications:

Do not use in livestock that produce milk for human consumption.

Do not use in horse.

Do not inject in mammary tissue.

Do not use in young growing animals due to potential cartilage abnormalities.

Do not administer concurrently with macrolides and tetracyclines,

Caution:

Hypersensitivity reactions may potentially occur.

Animals should not be dehydrated during therapy.

The drug is not recommended to be used during pregnancy unless the benefits of therapy clearly outweigh the risks.

Keep out of reach and sight of children.

Use only under the prescription of a veterinarian.

Storage:

Do not store above 25 °C, keep away from light and freezing.

In use stability:

28 days after first needle insertion

Packing:

50 ml vial in a box

For veterinary use only

Reviews

There are no reviews yet.

Be the first to review “Enroflak®5%”

Your email address will not be published. Required fields are marked *

Reviews

There are no reviews yet.

Be the first to review “Enroflak®5%”

Your email address will not be published. Required fields are marked *